News
NTHI ▼ -5.6% - NeOnc Technologies Holdings, Inc.
NTHI ▼ -5.6% - NeOnc Technologies Holdings, Inc.
$NTHI - Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
NeOnc Technologies Holdings fell 5.6% today despite a headline highlighting the company's cancer-fighting therapies and patented platform technology. The decline occurred without accompanying news of clinical setbacks or regulatory challenges, suggesting the market move may reflect broader sector pressure or profit-taking rather than company-specific negative developments.
15-SEP-2026 09:53 AM ET
Share this post
More filings for $NTHI
NTHI ▲ +18.3% - NeOnc Technologies Holdings, Inc.Oct 23, 2026NTHI ▲ +3.4% - NeOnc Technologies Holdings, Inc.Oct 22, 2026NTHI ▲ +2.8% - NeOnc Technologies Holdings, Inc.Oct 22, 2026NTHI ▲ +1.1% - NeOnc Technologies Holdings, Inc.Oct 21, 2026NTHI ▼ -2.2% - NeOnc Technologies Holdings, Inc.Oct 21, 2026NTHI ▲ +4.1% - NeOnc Technologies Holdings, Inc.Oct 20, 2026
View full $NTHI filing history →💬 Comments
Loading comments…
Leave a comment
